Adamant Health

Adamant Health’s precision technology measures Parkinson’s motor symptoms to provide objective data for patient-clinician discussions.

The patient diary, particularly developed for the Adamant Health measurement and analysis service for Parkinson's disease, offers an easy and secure way to collect accurate information on the patient's medication intakes, symptoms, and well-being for clinical use.

Adamant Health’s AI-powered technology combines electromyography (EMG) and accelerometry to assess Parkinson’s motor symptoms accurately.

The Adamant Health measurement and analysis service collects symptom data over time to help clinicians assess Parkinson’s patients holistically, using EMG and kinematic measurements.

A study with VTT Technical Research Center of Finland, the University of Eastern Finland, and Kuopio University Hospital found distinct healthcare-use patterns in people nearly 18 months before a Parkinson’s diagnosis.

PD Dr. Annette Rogge highlights that good Parkinson’s care extends beyond specialized treatment, drawing on her experience as a neurologist.

Adamant Health’s electromyography (EMG) and motion-based technology builds on over 15 years of research. The page provides an overview of scientific articles, abstracts, and conference papers related to Parkinson’s disease and epilepsy.

Adamant Health and Neurohope Health partner to introduce EMG-based symptom measurement in Spain, aiming to improve Parkinson’s disease management.

PD Dr. Annette Rogge discusses Adamant Health’s EMG and kinematic measurements at the German Neurological Society Congress, focusing on clinical assessment and individualized treatment.

Adamant Health presents its symptom measurement and analysis technology at the German Society of Neurology Congress in Berlin (4–7 November 2026).

Adamant Health seeks a Data Analyst & Scientist to analyze patient data and generate symptom reports for customers.

Adamant Health recruits a Clinical Trial Manager to oversee post-market clinical investigations of its medical device in Finland and Germany.

Adamant Health is hiring a Director of Finance and Operations to shape financial and operational strategies.

Adamant Health offers a Junior Health Data Analyst role to create symptom reports for clinics using biosignal data.

Adamant Health updated its pricing for Parkinson’s disease measurement and analysis in Finland for public sector healthcare providers.

Adamant Health provides data-driven symptom measurement for Parkinson’s patients to improve treatment accuracy and quality of life.

The page describes Adamant Health’s measurement and analysis service for Parkinson’s disease, enabling clinicians to track motor symptoms over time.

Adamant Health offers a measurement and analysis service for Parkinson’s disease.

The page invites meetings to discuss Adamant Health’s technology and measurement service for Parkinson’s disease.

Adamant Health offers technology and measurement services to support Parkinson’s symptom management.

Adamant Health’s solution enables data-driven care for Parkinson’s disease and movement disorders, supporting early detection and personalized treatment.

Adamant Health’s solution enables data-driven care for Parkinson’s disease and movement disorders, supporting early detection and personalized treatment.

Adamant Health explains how it collects, uses, stores, and protects personal data under applicable data protection laws.

Legal notice and company information for Adamant Health, including contact details, company registration, and other legally required disclosures.

Adamant Health and Neurohope Health collaborate to introduce electromyography (EMG)-based symptom measurement in Spain. The partnership aims to improve Parkinson’s disease diagnosis and treatment by helping clinicians identify patients suited for advanced therapies. The initiative supports a more precise and proactive approach to managing Parkinson’s care.

Sep 2026Adamant HealthNews article

Adamant Health and Gerresheimer collaborate to develop solutions for Parkinson’s disease management. The partnership combines Adamant’s healthtech expertise with Gerresheimer’s medtech capabilities. Together, they aim to enhance treatment options and patient outcomes for individuals with Parkinson’s.

Jun 2022University of Eastern FinlandNews article

Adamant Health partners with Gerresheimer to advance Parkinson’s treatment using electromyography (EMG) technology. The system tracks medication effects on motor symptoms in real-world settings, enabling doctors to adjust therapies more precisely. Pharma companies gain access to field data for developing improved drugs.

Jun 2022Adamant HealthNews article

Gerresheimer and MedTech start-up Adamant Health collaborate to develop a technology-based solution aimed at improving Parkinson’s disease treatment. The partnership targets a global patient population, leveraging combined expertise to introduce innovative approaches in drug delivery or therapeutic methods. Both companies focus on addressing unmet medical needs in neurodegenerative care.

Jun 2022PR NewswireNews article